{"title": "Synthesis, antiviral, cytotoxic and cytostatic evaluation of N1-(phosphonoalkyl)uracil derivatives", "body": "Acyclic nucleoside and nucleotide analogues have been used in clinical practice for almost 50 years and have become cornerstones in the treatment of patients with viral infections [1\u20133]. Nucleoside analogues such as acyclovir, ganciclovir, and penciclovir as well as acyclic nucleoside phosphonates (ANPs), namely adefovir, cidofovir, and tenofovir, belong to the most widely used antiviral drugs (Fig. 1) [4\u20136]. The ribose moiety in natural nucleosides/nucleotides was replaced by linear or branched aliphatic units to obtain analogues with specific activity following activation by viral and/or cellular kinases. The antiviral activity of these compounds relies on enzyme inhibition or on incorporation as active metabolites into the viral nucleic acids resulting in inhibition of viral genome replication.\n\n\nIn the last decade, several new drugs, including nucleoside and nucleotide analogues, have been approved for the treatment of viral infections and in cancer chemotherapy. Many nucleoside/nucleotide analogues and their derivatives are currently under preclinical and clinical trials [7] which demonstrates how rapidly this area of research grows. However, some of these analogues have poor oral bioavailability and are associated with toxicity, limiting their application for treatment of cancer and viral infections. Moreover, a long-term treatment with antiviral drugs may result in lower sensitivity of the viruses to chemotherapeutics (drug resistance) [8, 9]. For this reason, a search for new compounds with higher antiviral and antitumor activities, good bioavailability, better solubility, and proper balance between efficacy and long-term toxicity still continues.\n\nThe known synthetic strategies to ANPs commonly apply alkylation of heterocyclic bases [10] while the construction of nucleobase skeletons from the appropriate terminal primary amines has been less frequently used [11\u201315]. Herein, we report on the efficient synthesis and biological evaluation of a new series of acyclic nucleotide analogues by application of the latter approach (Scheme 1).\n\n\nAll the synthesized compounds 5a\u20135d, 6a\u20136d, and 8a\u201310d were evaluated for their antiviral activities against a wide variety of DNA and RNA viruses, using the following cell-based assays: (a) human embryonic lung (HEL) cells: herpes simplex virus-1 (KOS), herpes simplex virus-2 (G), herpes simplex virus-1 (TK\u2212 ACVr KOS), vaccinia virus and vesicular stomatitis virus, human cytomegalovirus (AD-169 strain and Davis strain), varicella-zoster virus (TK+ VZV strain OKA and TK\u2212 VZV strain 07-1); (b) CEM cell cultures: human immunodeficiency virus (HIV-1 and HIV-2); (c) Vero cell cultures: para-influenza-3 virus, reovirus-1, Sindbis virus, Coxsackie virus B4, Punta Toro virus; (d) HeLa cell cultures: vesicular stomatitis virus, Coxsackie virus B4 and respiratory syncytial virus (RSV); (e) Crandell-Rees Feline Kidney (CRFK) cell cultures: feline corona virus (FIPV) and feline herpes virus (FHV); (f) Madin Darby Canine Kidney (MDCK) cell cultures: influenza A virus H1N1 subtype (A/PR/8), influenza A virus H3N2 subtype (A/HK/7/87) and influenza B virus (B/HK/5/72). Ganciclovir, cidofovir, acyclovir, brivudin, (S)-9-(2,3-dihydroxypropyl)adenine [(S)-DHPA], Hippeastrum hybrid agglutinin (HHA), Urtica dioica agglutinin (UDA), dextran sulfate (molecular weight 5000, DS-5000), ribavirin, oseltamivir carboxylate, amantadine, and rimantadine were used as the reference compounds. The antiviral activity was expressed as the EC50: the compound concentration required to reduce virus-plaque formation (VZV) or virus-induced cytopathogenicity by 50 % (other viruses). It was found that the acyclic phosphonate analogues 10a and 10d containing the N\n3-benzoyluracil group as a modified nucleobase exhibited noticeable activity. Thus, compound 10a showed activity against cytomegalovirus (AD-169 strain) in human embryonic lung (HEL) cells (EC50 = 45 \u00b5M), whereas compound 10d proved to be active against VZV (TK+ strain OKA and TK\u2212 strain 07-1) with EC50 = 43 and 53 \u00b5M, respectively. The antiviral activity of compound 10d against VZV TK\u2212 strain 07-1 appeared to be slightly better than the activity of acyclovir and brivudin used as reference compounds (EC50 = 160 and 103 \u00b5M, respectively). To rationalize the observed activity of the N\n3-benzoyl derivatives 10a and 10d one can refer to their easier transport through cell membranes in comparison to the precursors 5a and 5d which appeared inactive. After entering into the cell debenzoylation would provide nucleoside analogues capable of Watson-Crick bas pairing. Our previous results [44] support this conclusion.\n\nThe cytotoxicity of the test compounds toward uninfected host cells was defined as the minimum cytotoxic concentration (MCC) that causes a microscopically detectable alteration of normal cell morphology. The 50 % cytotoxic concentration (CC50), causing a 50 % decrease in cell viability was determined using a colorimetric 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay system. None of the tested compounds affected cell morphology of HEL, HeLa, Vero, MDCK, and CRFK cells (MCC or CC50) at compound concentrations up to 100 \u03bcM.\n\nThe cytostatic activity of the tested compounds was defined as the 50 % inhibitory concentration (IC50), or compound concentration causing a 50 % decrease in cell proliferation. IC50 values were determined against murine leukemia L1210 cells, human lymphocyte CEM cells and human cervical carcinoma HeLa cells. Several synthesized compounds showed marginal inhibitory effect on the proliferation of HeLa cells at concentrations lower than 200 \u03bcM (Table 1).\n\n\nA series of N\n1-(phosphonoalkyl)uracils 5a\u20135d has been efficiently obtained from \u03c9-aminoalkylphosphonates 2a\u20132d in a two-step process which involved a reaction with (E)-3-ethoxyacryloyl isocyanate followed by the uracil ring closure. The uracil phosphonates 5a\u20135d were successfully transformed into 5-chloro-, 5-bromo-, and 5-iodouracils as well as N\n3-benzoyluracils. All synthesized compounds were tested in vitro for their antiviral activities against a broad variety of DNA and RNA viruses and compound 10a was slightly active against human cytomegalovirus in HEL cell cultures (EC50 = 45 \u03bcM) while 10d showed activity against both TK+ and TK-VZV strains with EC50 values of 43 \u00b5M (Oka strain) and of 53 \u00b5M (07-1 strain), which was two to threefold better than the potency of acyclovir and brivudin against 07-1 (EC50 = 160 and 103 \u00b5M, respectively).\n\nAmong them, several compounds exhibited a very poor inhibitory effect on the proliferation of human cervical carcinoma cells (HeLa) at a concentration lower than 200 \u03bcM. In contrast, none of the compounds affected the proliferation of CEM cells and L1210 cells up to a concentration of 250 \u00b5M.\n\nPale yellow oil; yield 13 %; IR (film): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3436, 2984, 2936, 2910, 1648, 1227, 1053, 1027, 964 cm\u22121; 1H NMR (600 MHz, CDCl3): \u03b4 = 4.14\u20134.04 (m, 8H, 4 \u00d7 POCH\n2CH3), 2.68 (t, J = 6.4 Hz, 4H, 2 \u00d7 CH\n2CH2CH2P), 2.03 (br s, 1H, NH), 1.82\u20131.73 (m, 8H, 2 \u00d7 CH\n2CH\n2P), 1.32 (t, J = 7.1 Hz, 12H, 4 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CDCl3): \u03b4 = 61.5 (d, J = 6.4 Hz, POC), 49.7 (d, J = 16.7 Hz, CCCP), 23.4 (d, J = 142.1 Hz, CP), 22.8 (d, J = 4.7 Hz, CCP), 16.4 (d, J = 5.7 Hz, POCC) ppm; 31P NMR (243 MHz, CDCl3): \u03b4 = 32.20 ppm.\n\n\nDiethyl 4-aminobutylphosphonate (2d) [19, 27]\n\nYellowish oil; yield 70 %.\n\nPale yellow oil; yield 23 %; IR (film): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3441, 2982, 2936, 1642, 1230, 1052, 1026, 962 cm\u22121; 1H NMR (600 MHz, CDCl3): \u03b4 = 4.13\u20134.03 (m, 8H, 4 \u00d7 POCH\n2CH3), 2.59 (t, J = 7.1 Hz, 4H, 2 \u00d7 CH\n2CH2CH2CH2P), 2.00 (br s, 1H, NH), 1.76\u20131.70 (m, 4H, 2 \u00d7 CH2P), 1.66\u20131.54 (m, 8H, 2 \u00d7 CH\n2CH\n2CH2P), 1.31 (t, J = 7.1 Hz, 12H, 4 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CDCl3): \u03b4 = 61.4 (d, J = 6.5 Hz, POC), 49.3 (s, CCCCP), 30.9 (d, J = 16.0 Hz, CCCP), 25.6 (d, J = 140.9 Hz, CP), 20.3 (d, J = 5.2 Hz, CCP), 16.4 (d, J = 6.2 Hz, POCC) ppm; 31P NMR (243 MHz, CDCl3): \u03b4 = 32.07 ppm.\n\nCreamy solid; yield 79 %; m.p.: 56\u201358 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3428, 3239, 3133, 2984, 2936, 1684, 1617, 1563, 1304, 1229, 1168, 1120, 1054, 1023, 979, 807 cm\u22121; 1H NMR (300 MHz, CDCl3): \u03b4 = 10.00 (br s, 1H, NH), 9.01 (dt, J = 5.9, 1.9 Hz, 1H, HNCH2), 7.66 (d, J = 12.3 Hz, 1H, EtOCH=CH), 5.39 (d, J = 12.3 Hz, 1H, EtOCH=CH), 4.22\u20134.12 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.97 (q, J = 6.9 Hz, 2H, OCH\n2CH3), 3.77 (dd, J = 11.9, 5.9 Hz, 2H, CH2P), 1.37 (t, J = 6.9 Hz, 3H, OCH2CH\n3), 1.34 (t, J = 7.2 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (75.5 MHz, CDCl3): \u03b4 = 168.3 (s, C=O), 162.9 (s, EtOCH=CH), 155.5 (d, J = 6.6 Hz, C=O), 98.0 (s, EtOCH=CH), 67.7 (s, OCH2CH3), 62.7 (d, J = 6.3 Hz, POC), 35.3 (d, J = 157.2 Hz, CP), 16.6 (d, J = 5.7 Hz, POCC), 14.7 (s, OCH2\nCH3) ppm; 31P NMR (121.5 MHz, CDCl3): \u03b4 = 23.25 ppm.\n\nColorless solid; yield 65 %; m.p.: 61\u201363 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3297, 3231, 3149, 3102, 2984, 2938, 1705, 1680, 1618, 1536, 1227, 1164, 1032, 965, 846 cm\u22121; 1H NMR (300 MHz, CDCl3): \u03b4 = 9.81 (br s, 1H, NH), 8.92 (t, J = 5.7 Hz, 1H, HNCH2), 7.64 (d, J = 12.3 Hz, 1H, EtOCH=CH), 5.38 (d, J = 12.3 Hz, 1H, EtOCH=CH), 4.21\u20134.00 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.97 (q, J = 7.2 Hz, 2H, OCH\n2CH3), 3.58 (dt, J = 14.7, 7.2 Hz, 2H, CH\n2CH2P), 2.08 (dt, J = 18.0, 7.2 Hz, 2H, CH2P), 1.36 (t, J = 7.2 Hz, 3H, OCH2CH\n3), 1.34 (t, J = 7.2 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (75.5 MHz, CDCl3): \u03b4 = 168.1 (s, C=O), 162.7 (s, EtOCH=CH), 155.4 (s, C=O), 98.2 (s, EtOCH=CH), 67.6 (s, OCH2CH3), 62.0 (d, J = 6.6 Hz, POC), 34.2 (d, J = 3.1 Hz, CCP), 26.5 (d, J = 139.1 Hz, CP), 16.7 (d, J = 6.0 Hz, POCC), 14.8 (s, OCH2\nCH3) ppm; 31P NMR (121.5 MHz, CDCl3): \u03b4 = 29.76 ppm.\n\nYellow oil; yield 73 %; IR (film): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3285, 3140, 2981, 1681, 1613, 1548, 1242, 1167, 1105, 1027, 966 cm\u22121; 1H NMR (300 MHz, CDCl3): \u03b4 = 9.67 (br s, 1H, NH), 8.76 (t, J = 6.0 Hz, 1H, HNCH2), 7.64 (d, J = 12.3 Hz, 1H, EtOCH=CH), 5.38 (d, J = 12.3 Hz, 1H, EtOCH=CH), 4.16\u20134.04 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.98 (q, J = 7.0 Hz, 2H, OCH\n2CH3), 3.38 (dt, J = 12.6, 6.0 Hz, 2H, CH\n2CH2CH2P), 1.94\u20131.72 (m, 4H, CH\n2CH\n2P), 1.36 (t, J = 7.0 Hz, 3H, OCH2CH\n3), 1.32 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (75.5 MHz, CDCl3): \u03b4 = 168.4 (s, C=O), 162.5 (s, EtOCH=CH), 155.5 (s, C=O), 98.1 (s, EtOCH=CH), 67.4 (s, OCH2CH3), 61.7 (d, J = 6.3 Hz, POC), 39.9 (d, J = 18.0 Hz, CCCP), 23.2 (d, J = 142.6 Hz, CP), 23.0 (d, J = 4.9 Hz, CCP), 16.6 (d, J = 6.0 Hz, POCC), 14.6 (s, OCH2\nCH3) ppm; 31P NMR (121.5 MHz, CDCl3): \u03b4 = 32.56 ppm.\n\nYellowish oil; yield 72 %; IR (film): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3421, 3283, 3144, 3103, 2982, 2941, 1704, 1679, 1617, 1549, 1234, 1168, 1105, 1057, 1027, 965, 819 cm\u22121; 1H NMR (300 MHz, CDCl3): \u03b4 = 9.52 (br s, 1H, NH), 8.68 (t, J = 5.8 Hz, 1H, HNCH2), 7.63 (d, J = 12.2 Hz, 1H, EtOCH=CH), 5.36 (d, J = 12.2 Hz, 1H, EtOCH=CH), 4.15\u20134.03 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.97 (q, J = 7.0 Hz, 2H, OCH\n2CH3), 3.31 (dt, J = 6.4, 5.8 Hz, 2H, CH\n2CH2CH2CH2P), 1.81\u20131.62 (m, 6H, CH\n2CH\n2CH\n2P), 1.36 and 1.32 (2t, J = 6.9 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CDCl3): \u03b4 = 168.4 (s, C=O), 162.4 (s, EtOCH=CH), 155.5 (s, C=O), 98.2 (s, EtOCH=CH), 67.2 (s, OCH2CH3), 61.5 (d, J = 6.6 Hz, POC), 38.9 (s, CCCCP), 30.4 (d, J = 15.5 Hz, CCCP), 25.2 (d, J = 141.8 Hz, CP), 19.8 (d, J = 5.5 Hz, CCP), 16.3 (d, J = 6.3 Hz, POCC), 14.4 (s, OCH2\nCH3) ppm; 31P NMR (121.5 MHz, CDCl3): \u03b4 = 32.19 ppm.\n\nWhite solid; yield 58 %; m.p.: 122\u2013124 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3428, 3172, 3057, 2991, 2870, 2822, 1689, 1632, 1452, 1382, 1343, 1239, 1049, 977, 732 cm\u22121; 1H NMR (300 MHz, CDCl3): \u03b4 = 9.29 (br s, 1H, NH), 7.35 (d, J = 7.9 Hz, 1H, HC-6), 5.76 (dd, J = 7.9, 1.4 Hz, 1H, HC-5), 4.19 (dq, J = 7.9, 6.9 Hz, 4H, 2 \u00d7 POCH\n2CH3), 4.17 (d, J = 11.5 Hz, 2H, CH2P), 1.34 (t, J = 6.9 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (75.5 MHz, CDCl3): \u03b4 = 163.8 (s, C=O), 150.6 (d, J = 2.0 Hz, C=O), 144.2 (s, C-6), 102.9 (s, C-5), 63.5 (d, J = 6.6 Hz, POC), 42.0 (d, J = 156.3 Hz, CP), 16.6 (d, J = 6.0 Hz, POCC) ppm; 31P NMR (121.5 MHz, CDCl3): \u03b4 = 19.35 ppm.\n\n\nDiethyl 2-[3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl]ethylphosphonate (5b) [46, 47]\n\nColorless oil; yield: 83 %.\n\n\nDiethyl 3-[3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl]propylphosphonate (5c) [46, 47]\n\nColorless oil; yield: 84 %.\n\n\nDiethyl 4-[3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl]butylphosphonate (5d) [46, 47]\n\nColorless oil; yield: 85 %.\n\nColorless solid; yield 72 % [after column chromatography (ethyl acetate) and crystallization from ethyl acetate-petroleum ether mixture]; m.p.: 136\u2013138 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3406, 3172, 3043, 2984, 2945, 2831, 1712, 1690, 1633, 1338, 1224, 1061, 1012, 971 cm\u22121; 1H NMR (300 MHz, CDCl3): \u03b4 = 9.92 (br s, 1H, NH), 7.61 (s, 1H, HC-6), 4.21 (dq, J = 7.9, 6.9 Hz, 4H, 2 \u00d7 POCH\n2CH3), 4.19 (d, J = 10.7 Hz, 2H, CH2P), 1.35 (t, J = 6.9 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (75.5 MHz, CDCl3): \u03b4 = 159.4 (s, C=O), 149.9 (d, J = 2.0 Hz, C=O), 141.0 (s, C-6), 109.4 (s, C-5), 63.6 (d, J = 6.3 Hz, POC), 42.2 (d, J = 156.0 Hz, CP), 16.6 (d, J = 6.0 Hz, POCC) ppm; 31P NMR (121.5 MHz, CDCl3): \u03b4 = 18.80 ppm.\n\nCreamy solid; yield 69 % [after column chromatography (chloroform/methanol 100:1 v/v)]; m.p.: 149\u2013151 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3171, 3029, 2994, 2926, 2839, 1701, 1665, 1631, 1368, 1250, 1069, 1018, 963, 793 cm\u22121; 1H NMR (600 MHz, CDCl3): \u03b4 = 9.18 (br s, 1H, NH), 7.61 (s, 1H, HC-6), 4.19\u20134.10 (m, 4H, 2 \u00d7 POCH\n2CH3), 4.05 (dt, J = 16.1, 6.8 Hz, 2H, CH\n2CH2P), 2.26 (dt, J = 18.2, 6.8 Hz, 2H, CH2P), 1.35 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CDCl3): \u03b4 = 159.6 (s, C=O), 149.9 (s, C=O), 142.2 (s, C-6), 108.4 (s, C-5), 62.3 (d, J = 6.4 Hz, POC), 44.6 (d, J = 3.0 Hz, CCP), 25.0 (d, J = 140.9 Hz, CP), 16.4 (d, J = 5.7 Hz, POCC) ppm; 31P NMR (243 MHz, CDCl3): \u03b4 = 26.78 ppm.\n\nColorless solid; yield 53 % (after column chromatography (ethyl acetate) and crystallization from ethyl acetate-petroleum ether mixture); m.p.: 64\u201366 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3545, 3044, 2988, 1701, 1654, 1624, 1458, 1272, 1242, 1227, 1015, 962 cm\u22121; 1H NMR (300 MHz, CDCl3): \u03b4 = 9.95 (br s, 1H, NH), 7.63 (s, 1H, HC-6), 4.24\u20134.07 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.90 (t, J = 7.2 Hz, 2H, CH\n2CH2CH2P), 2.06 (dqu, J = 14.6, 7.2 Hz, 2H, CH\n2CH2P), 1.81 (dt, J = 18.2, 7.2 Hz, 2H, CH2P), 1.36 (t, J = 6.9 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (75.5 MHz, CDCl3): \u03b4 = 159.7 (s, C=O), 150.2 (s, C=O), 141.6 (s, C-6), 108.8 (s, C-5), 62.2 (d, J = 6.6 Hz, POC), 49.1 (d, J = 14.6 Hz, CCCP), 22.4 (d, J = 142.8 Hz, CP), 22.3 (d, J = 4.9 Hz, CCP), 16.7 (d, J = 5.7 Hz, POCC) ppm; 31P NMR (121.5 MHz, CDCl3): \u03b4 = 31.35 ppm.\n\nColorless oil; yield 6 % [after column chromatography (ethyl acetate)]; IR (film): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3229, 3077, 2925, 2852, 1745, 1696, 1471, 1240, 1098, 1024, 970 cm\u22121; 1H NMR (300 MHz, CDCl3): \u03b4 = 8.18 (br s, 1H, NH), 5.14 (s, 1H, HC-5), 4.19\u20134.02 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.86 (dt, J = 13.9, 7.0 Hz, 1H, CH\naHbCH2CH2CH2P), 3.47 (dt, J = 13.9, 6.8 Hz, 1H, CHa\nH\nbCH2CH2CH2P), 2.18\u20131.84 (m, 4H, CH\n2CH\n2P), 1.34 and 1.32 (2 \u00d7 t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CDCl3): \u03b4 = 161.5 (s, C=O), 150.6 (s, C=O), 86.3 (s, C-6), 79.5 (s, C-5), 62.5 (d, J = 6.4 Hz, POC), 62.2 (d, J = 6.8 Hz, POC), 47.8 (d, J = 13.5 Hz, CCCP), 22.1 (d, J = 142.4 Hz, CP), 21.1 (d, J = 4.3 Hz, CCP), 16.4 (d, J = 6.6 Hz, POCC), 16.3 (d, J = 5.3 Hz, POCC) ppm; 31P NMR (121.5 MHz, CDCl3): \u03b4 = 33.88 ppm.\n\nWhite solid; yield 65 % (after column chromatography (hexane/ethyl acetate 2:1, 1:2 v/v) and crystallization from ethyl acetate-hexane mixture); m.p.: 139\u2013142 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3150, 2982, 2947, 2818, 1688, 1627, 1451, 1429, 1355, 1245, 1210, 1187, 1045, 1020, 971 cm\u22121; 1H NMR (300 MHz, CDCl3): \u03b4 = 9.38 (br s, 1H, NH), 7.45 (s, 1H, HC-6), 4.17\u20134.04 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.76 (t, J = 7.3 Hz, 2H, CH\n2CH2CH2CH2P), 1.88\u20131.61 (m, 6H, CH\n2CH\n2CH\n2P), 1.33 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (75.5 MHz, CDCl3): \u03b4 = 159.6 (s, C=O), 150.1 (s, C=O), 141.2 (s, C-6), 108.8 (s, C-5), 61.9 (d, J = 6.6 Hz, POC), 48.8 (s, CCCCP), 29.7 (d, J = 14.3 Hz, CCCP), 25.2 (d, J = 141.7 Hz, CP), 19.7 (d, J = 4.9 Hz, CCP), 16.7 and 16.6 (2 \u00d7 d, J = 5.9 Hz, POCC) ppm; 31P NMR (121.5 MHz, CDCl3): \u03b4 = 31.46 ppm.\n\nWhite solid; yield 12 % [after column chromatography (hexane/ethyl acetate 2:1, 1:2 v/v)]; m.p.: 138\u2013141 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3412, 3231, 2961, 2924, 2854, 1745, 1698, 1482, 1439, 1254, 1027 cm\u22121; 1H NMR (300 MHz, CDCl3): \u03b4 = 8.60 (br s, 1H, NH), 5.11 (s, 1H, HC-5), 4.16\u20133.98 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.67 (dt, J = 13.7, 7.0 Hz, 1H, CH\naHbCH2CH2CH2P), 3.49 (dt, J = 13.7, 7.1 Hz, 1H, CHa\nH\nbCH2CH2CH2P), 1.94\u20131.65 (m, 6H, CH\n2CH\n2CH\n2P), 1.32 and 1.31 (2 \u00d7 t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CDCl3): \u03b4 = 161.6 (s, C=O), 150.6 (s, C=O), 85.6 (s, C-6), 79.5 (s, C-5), 62.2 (d, J = 6.5 Hz, POC), 62.0 (d, J = 7.1 Hz, POC), 46.3 (s, CCCCP), 28.2 (d, J = 11.7 Hz, CCCP), 24.3 (d, J = 141.3 Hz, CP), 19.1 (d, J = 4.8 Hz, CCP), 16.4 (d, J = 6.6 Hz, POCC), 16.3 (d, J = 6.6 Hz, POCC) ppm; 31P NMR (121.5 MHz, CDCl3): \u03b4 = 33.19 ppm.\n\nWhite solid; yield 69 % (after column chromatography (hexane/ethyl acetate 1:2 and ethyl acetate v/v) and crystallization from ethyl acetate-petroleum ether mixture); m.p.: 120\u2013122 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3415, 3164, 3040, 2943, 2851, 1707, 1626, 1422, 1338, 1224, 1012, 985 cm\u22121; 1H NMR (300 MHz, CDCl3): \u03b4 = 10.06 (br s, 1H, NH), 7.72 (s, 1H, HC-6), 4.21 (dq, J = 8.1, 7.0 Hz, 4H, 2 \u00d7 POCH\n2CH3), 4.20 (d, J = 11.1 Hz, 2H, CH2P), 1.35 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (75.5 MHz, CDCl3): \u03b4 = 159.5 (s, C=O), 150.1 (d, J = 2.0 Hz, C=O), 143.5 (s, C-6), 97.2 (s, C-5), 63.6 (d, J = 6.6 Hz, POC), 42.2 (d, J = 156.0 Hz, CP), 16.6 (d, J = 6.0 Hz, POCC) ppm; 31P NMR (121.5 MHz, CDCl3): \u03b4 = 18.82 ppm.\n\nWhite solid; yield 75 % (after column chromatography (chloroform/methanol 200:1 v/v) and crystallization from ethyl acetate-petroleum ether mixture); m.p.: 134\u2013135 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3162, 3038, 2990, 2834, 1704, 1660, 1623, 1251, 1054, 1016, 962 cm\u22121; 1H NMR (300 MHz, CDCl3): \u03b4 = 10.06 (br s, 1H, NH), 7.73 (s, 1H, HC-6), 4.19\u20134.03 (m, 4H, 2 \u00d7 POCH\n2CH3), 4.02 (dt, J = 16.2, 6.9 Hz, 2H, CH\n2CH2P), 2.23 (dt, J = 18.0, 6.9 Hz, 2H, CH2P), 1.30 (t, J = 6.8 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (75.5 MHz, CDCl3): \u03b4 = 159.9 (s, C=O), 150.3 (s, C=O), 144.8 (s, C-6), 96.1 (s, C-5), 62.5 (d, J = 6.6 Hz, POC), 44.6 (d, J = 3.4 Hz, CCP), 25.2 (d, J = 140.3 Hz, CP), 16.6 (d, J = 6.0 Hz, POCC) ppm; 31P NMR (121.5 MHz, CDCl3): \u03b4 = 27.46 ppm.\n\nCreamy solid; yield 85 % [after column chromatography (chloroform/methanol 200:1 v/v)]; m.p.: 48\u201350 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3549, 3504, 3162, 3052, 2986, 2824, 1702, 1618, 1452, 1346, 1272, 1242, 1180, 1014, 962 cm\u22121; 1H NMR (300 MHz, CDCl3): \u03b4 = 9.84 (br s, 1H, NH), 7.72 (s, 1H, HC-6), 4.22\u20134.04 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.88 (t, J = 7.2 Hz, 2H, CH\n2CH2CH2P), 2.04 (dqu, J = 15.0, 7.2 Hz, 2H, CH\n2CH2P), 1.78 (dt, J = 18.0, 7.2 Hz, 2H, CH2P), 1.34 (t, J = 6.8 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (75.5 MHz, CDCl3): \u03b4 = 159.9 (s, C=O), 150.5 (s, C=O), 144.2 (s, C-6), 96.5 (s, C-5), 62.2 (d, J = 6.6 Hz, POC), 49.0 (d, J = 15.2 Hz, CCCP), 22.4 (d, J = 142.6 Hz, CP), 22.3 (d, J = 4.9 Hz, CCP), 16.6 (d, J = 6.0 Hz, POCC) ppm; 31P NMR (121.5 MHz, CDCl3): \u03b4 = 31.36 ppm.\n\nWhite solid; yield 85 % (after column chromatography (chloroform/methanol 200:1 v/v) and crystallization from ethyl acetate-petroleum ether mixture); m.p.: 112\u2013114 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3141, 3074, 2980, 2928, 2817, 1705, 1686, 1621, 1424, 1353, 1247, 1211, 1040, 959 cm\u22121; 1H NMR (300 MHz, CDCl3): \u03b4 = 9.36 (br s, 1H, NH), 7.56 (s, 1H, HC-6), 4.17\u20134.02 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.77 (t, J = 7.2 Hz, 2H, CH\n2CH2CH2CH2P), 1.88\u20131.61 (m, 6H, CH\n2CH\n2CH\n2P), 1.33 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (75.5 MHz, CDCl3): \u03b4 = 159.6 (s, C=O), 150.3 (s, C=O), 143.8 (s, C-6), 96.6 (s, C-5), 61.9 (d, J = 6.6 Hz, POC), 48.8 (s, CCCCP), 29.8 (d, J = 14.3 Hz, CCCP), 25.2 (d, J = 141.7 Hz, CP), 19.7 (d, J = 4.9 Hz, CCP), 16.7 and 16.6 (2 \u00d7 d, J = 6.0 Hz, POCC) ppm; 31P NMR (121.5 MHz, CDCl3): \u03b4 = 31.46 ppm.\n\nColorless solid; yield 72 % (after crystallization from ethyl alcohol-petroleum ether); m.p.: 116\u2013118 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3156, 3008, 2984, 2929, 2827, 1694, 1613, 1418, 1352, 1226, 1055, 1017, 967 cm\u22121; 1H NMR (300 MHz, CDCl3): \u03b4 = 9.24 (br s, 1H, NH), 7.78 (s, 1H, HC-6), 4.20 (dq, J = 8.1, 7.0 Hz, 4H, 2 \u00d7 POCH\n2CH3), 4.17 (d, J = 11.3 Hz, 2H, CH2P), 1.35 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (75.5 MHz, CDCl3): \u03b4 = 160.4 (s, C=O), 150.3 (d, J = 2.0 Hz, C=O), 148.5 (s, C-6), 68.8 (s, C-5), 63.6 (d, J = 6.6 Hz, POC), 42.2 (d, J = 155.7 Hz, CP), 16.6 and 16.5 (2 \u00d7 d, J = 6.0 Hz, POCC) ppm; 31P NMR (121.5 MHz, CDCl3): \u03b4 = 18.02 ppm.\n\nColorless oil; yield 77 %; IR (film): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3473, 3167, 3051, 2984, 2817, 1691, 1613, 1443, 1420, 1359, 1284, 1226, 1097, 1051, 1024, 973, 794 cm\u22121; 1H NMR (300 MHz, CDCl3): \u03b4 = 10.04 (br s, 1H, NH), 7.84 (s, 1H, HC-6), 4.21\u20134.04 (m, 4H, 2 \u00d7 POCH\n2CH3), 4.04 (dt, J = 15.7, 6.9 Hz, 2H, CH\n2CH2P), 2.25 (dt, J = 18.2, 6.9 Hz, 2H, CH2P), 1.32 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (75.5 MHz, CDCl3): \u03b4 = 161.0 (s, C=O), 150.6 (s, C=O), 149.7 (s, C-6), 67.7 (s, C-5), 62.5 (d, J = 6.3 Hz, POC), 44.5 (d, J = 2.6 Hz, CCP), 25.2 (d, J = 140.3 Hz, CP), 16.6 (d, J = 5.7 Hz, POCC) ppm; 31P NMR (121.5 MHz, CDCl3): \u03b4 = 27.49 ppm.\n\nWhite solid; yield 71 % (after crystallization from chloroform\u2013diethyl ether mixture); m.p.: 82\u201384 \u00b0C.\n\nColorless oil; yield 91 %; IR (film): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3445, 3165, 3050, 2984, 2816, 1690, 1612, 1441, 1420, 1228, 1051, 1026, 966 cm\u22121; 1H NMR (300 MHz, CDCl3): \u03b4 = 9.63 (br s, 1H, NH), 7.67 (s, 1H, HC-6), 4.18\u20134.02 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.77 (t, J = 7.1 Hz, 2H, CH\n2CH2CH2CH2P), 1.88\u20131.61 (m, 6H, CH\n2CH\n2CH\n2P), 1.33 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (75.5 MHz, CDCl3): \u03b4 = 160.9 (s, C=O), 150.7 (s, C=O), 148.8 (s, C-6), 68.1 (s, C-5), 61.9 (d, J = 6.6 Hz, POC), 48.6 (s, CCCCP), 29.8 (d, J = 14.9 Hz, CCCP), 25.1 (d, J = 142.0 Hz, CP), 19.6 (d, J = 3.7 Hz, CCP), 16.8 and 16.7 (2 \u00d7 d, J = 5.9 Hz, POCC) ppm; 31P NMR (121.5 MHz, CDCl3): \u03b4 = 31.55 ppm.\n\nColorless oil; yield 63 %; IR (film): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3482, 3090, 2988, 2939, 1750, 1706, 1668, 1598, 1437, 1381, 1341, 1241, 1047, 1023, 976 cm\u22121; 1H NMR (600 MHz, CDCl3): \u03b4 = 7.95\u20137.94 (m, 2H), 7.68\u20137.66 (m, 1H), 7.53\u20137.50 (m, 2H), 7.44 (d, J = 8.0 Hz, 1H, HC-6), 5.87 (d, J = 8.0 Hz, 1H, HC-5), 4.16\u20134.09 (m, 4H, 2 \u00d7 POCH\n2CH3), 4.18 (d, J = 11.3 Hz, 2H, CH2P), 1.34 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CDCl3): \u03b4 = 168.2 (s, C=O), 162.0 (s, C=O), 149.5 (d, J = 2.3 Hz, C=O), 143.8 (s, C-6), 135.2, 131.3, 130.5, 129.2, 102.7 (s, C-5), 63.4 (d, J = 6.5 Hz, POC), 42.2 (d, J = 155.7 Hz, CP), 16.3 (d, J = 5.7 Hz, POCC) ppm; 31P NMR (243 MHz, CDCl3): \u03b4 = 17.86 ppm.\n\nColorless oil; yield 64 %; IR (film): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3494, 3088, 2984, 2931, 2910, 1746, 1705, 1664, 1441, 1391, 1353, 1242, 1051, 1026, 987 cm\u22121; 1H NMR (600 MHz, CDCl3): \u03b4 = 7.96\u20137.95 (m, 2H), 7.68\u20137.66 (m, 1H), 7.53\u20137.50 (m, 2H), 7.41 (d, J = 8.0 Hz, 1H, HC-6), 5.81 (d, J = 8.0 Hz, 1H, HC-5), 4.18\u20134.09 (m, 4H, 2 \u00d7 POCH\n2CH3), 4.05 (dt, J = 15.9, 7.0 Hz, 2H, CH\n2CH2P), 2.26 (dt, J = 18.2, 7.0 Hz, 2H, CH2P), 1.36 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CDCl3): \u03b4 = 168.6 (s, C=O), 162.4 (s, C=O), 149.6 (s, C=O), 144.9 (s, C-6), 135.1, 131.5, 130.5, 129.2, 101.9 (s, C-5), 62.2 (d, J = 6.5 Hz, POC), 44.8 (d, J = 4.0 Hz, CCP), 24.9 (d, J = 140.7 Hz, CP), 16.4 (d, J = 6.0 Hz, POCC) ppm; 31P NMR (243 MHz, CDCl3): \u03b4 = 26.76 ppm.\n\nColorless oil; yield 56 %; IR (film): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3448, 3083, 2984, 2932, 1747, 1704, 1663, 1439, 1242, 1028, 967 cm\u22121; 1H NMR (600 MHz, CDCl3): \u03b4 = 7.95\u20137.94 (m, 2H), 7.68\u20137.66 (m, 1H), 7.53\u20137.51 (m, 2H), 7.43 (d, J = 8.0 Hz, 1H, HC-6), 5.83 (d, J = 8.0 Hz, 1H, HC-5), 4.18\u20134.08 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.91 (t, J = 7.5 Hz, 2H, CH\n2CH2CH2P), 2.07 (dqu, J = 14.9, 7.5 Hz, 2H, CH\n2CH2P), 1.79 (dt, J = 18.5, 7.5 Hz, 2H, CH2P), 1.35 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (150 MHz, CDCl3): \u03b4 = 168.7 (s, C=O), 162.4 (s, C=O), 149.8 (s, C=O), 144.4 (s, C-6), 135.1, 131.5, 130.4, 129.2, 102.2 (s, C-5), 61.9 (d, J = 6.6 Hz, POC), 49.0 (d, J = 13.7 Hz, CCCP), 22.3 (d, J = 143.0 Hz, CP), 22.2 (d, J = 4.6 Hz, CCP), 16.5 (d, J = 5.8 Hz, POCC) ppm; 31P NMR (243 MHz, CDCl3): \u03b4 = 29.96 ppm.\n\nColorless oil; yield 73 %; IR (film): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{\\nu } $$\\end{document}\u03bd\u00af = 3451, 3083, 2983, 2939, 2872, 1747, 1704, 1663, 1439, 1241, 1027, 963 cm\u22121; 1H NMR (600 MHz, CDCl3): \u03b4 = 7.94\u20137.93 (m, 2H), 7.67\u20137.65 (m, 1H), 7.52\u20137.50 (m, 2H), 7.30 (d, J = 8.0 Hz, 1H, HC-6), 5.81 (d, J = 8.0 Hz, 1H, HC-5), 4.14\u20134.04 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.78 (t, J = 7.3 Hz, 2H, CH\n2CH2CH2CH2P), 1.88\u20131.83 (m, 2H, CH\n2CH2CH2P), 1.81\u20131.76 (m, 2H, CH2P), 1.72\u20131.64 (m, 2H, CH\n2CH2P), 1.32 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (150 MHz, CDCl3): \u03b4 = 168.8 (s, C=O), 162.4 (s, C=O), 149.8 (s, C=O), 144.1 (s, C-6), 135.0, 131.6, 130.4, 129.2, 102.2 (s, C-5), 61.6 (d, J = 6.6 Hz, POC), 48.5 (s, CCCCP), 29.5 (d, J = 14.6 Hz, CCCP), 25.0 (d, J = 141.9 Hz, CP), 19.5 (d, J = 4.7 Hz, CCP), 16.4 (d, J = 5.7 Hz, POCC) ppm; 31P NMR (243 MHz, CDCl3): \u03b4 = 30.88 ppm.\n\nThe compounds were evaluated against the following viruses: herpes simplex virus type 1 (HSV-1) strain KOS, thymidine kinase-deficient (TK\u2212) HSV-1 KOS strain resistant to ACV (ACVr), herpes simplex virus type 2 (HSV-2) strains Lyons and G, varicella-zoster virus (VZV) strain Oka, TK\u2212 VZV strain 07-1, human cytomegalovirus (HCMV) strains AD-169 and Davis, vaccinia virus Lederle strain, respiratory syncytial virus (RSV) strain Long, vesicular stomatitis virus (VSV), Coxsackie B4, Parainfluenza 3, Influenza virus A (subtypes H1N1, H3N2), influenza virus B, Reovirus-1, Sindbis, Reovirus-1, Punta Toro, human immunodeficiency virus type 1 strain IIIB, and human immunodeficiency virus type 2 strain ROD. The antiviral, other than anti-HIV, assays were based on inhibition of virus-induced cytopathicity or plaque formation in human embryonic lung (HEL) fibroblasts, African green monkey cells (Vero), human epithelial cells (HeLa), or Madin-Darby canine kidney cells (MDCK). Confluent cell cultures in microtiter 96-well plates were inoculated with 100 CCID50 of virus (1 CCID50 being the virus dose to infect 50 % of the cell cultures) or with 20 plaque forming units (PFU) (VZV) in the presence of varying concentrations of the test compounds. Viral cytopathicity or plaque formation was recorded as soon as it reached completion in the control virus-infected cell cultures that were not treated with the test compounds. Antiviral activity was expressed as the EC50 or compound concentration required to reduce virus-induced cytopathogenicity or viral plaque formation by 50 %.\n\nThe methodology of the anti-HIV assays was as follows: human CEM (~3 \u00d7 105 cells/cm3) cells were infected with 100 CCID50 of HIV(IIIB) or HIV-2(ROD)/cm3 and seeded in 200 mm3 wells of a microtiter plate containing appropriate dilutions of the test compounds. After 4 days of incubation at 37 \u00b0C, HIV-induced CEM giant cell formation was examined microscopically.\n\nAll assays were performed in 96-well microtiter plates. To each well were added (5\u20137.5) \u00d7 104 tumor cells and a given amount of the test compound. The cells were allowed to proliferate for 48 h (murine leukemia L1210 cells) or 72 h (human lymphocytic CEM and human cervix carcinoma HeLa cells) at 37 \u00b0C in a humidified CO2-controlled atmosphere. At the end of the incubation period, the cells were counted in a Coulter counter. The IC50 (50 % inhibitory concentration) was defined as the concentration of the compound that inhibited cell proliferation by 50 %."}